Organization
Nagoya University Hospital Hematology Assistant Professor
Title
Assistant Professor
SATO Takahiko
Degree 2
-
博士（医学） （ 2025.3 名古屋大学 ）
-
学士（医学） （ 2012.3 名古屋大学 ）
Research Areas 2
-
Life Science / Immunology
-
Life Science / Hematology and medical oncology
Professional Memberships 5
-
日本内科学会
-
日本血液学会
-
日本造血・免疫細胞療法学会
-
日本癌学会
-
American Association for Cancer Research
Awards 2
-
第13回日本血液学会東海地方会最優秀演題賞
2024.6 日本血液学会東海地方会
-
Second Prize, Blood Cell Therapy Editorial Award
2021 The Asia-Pacific Blood and Marrow Transplantation Group
Papers 16
-
Sustained inhibition of CSF1R signaling augments antitumor immunity through inhibiting tumor-associated macrophages. Reviewed
Sato T, Sugiyama D, Koseki J, Kojima Y, Hattori S, Sone K, Nishinakamura H, Ishikawa T, Ishikawa Y, Kato T, Kiyoi H, Nishikawa H
Vol. 10 ( 1 ) 2025.1
-
Simple and early prediction of severe CAR-T-related adverse events after Axi-cel infusion by initial high fever. Reviewed
Wakabayashi H, Terakura S, Ishigiwa K, Ohara F, Hirano S, Yokota H, Kuwano S, Furukawa K, Shimada K, Sato T, Hanajiri R, Kiyoi H
2025.2
-
Autologous peripheral blood stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia is safe but poses challenges for long-term maintenance of molecular remission: Results of the Auto-Ph17 study. Reviewed
Nishiwaki S, Sugiura I, Sato T, Kobayashi M, Osaki M, Sawa M, Adachi Y, Okabe M, Saito S, Morishita T, Kohno A, Nishiyama T, Iida H, Kurahashi S, Kuwatsuka Y, Sugiyama D, Ito S, Nishikawa H, Kiyoi H
eJHaem Vol. 4 ( 2 ) page： 358 - 369 2023.5
-
Impact of HLA Epitope Matching on Outcomes After Unrelated Bone Marrow Transplantation. Reviewed
Iwasaki M, Kanda J, Tanaka H, Shindo T, Sato T, Doki N, Fukuda T, Ozawa Y, Eto T, Uchida N, Katayama Y, Kataoka K, Ara T, Ota S, Onizuka M, Kanda Y, Ichinohe T, Atsuta Y, Morishima S
Frontiers in immunology Vol. 13 page： 811733 2022
-
Assessment of cellular response to mitogens in long-term allogeneic hematopoietic stem cell transplantation survivors. Reviewed
Sato T, Goto M, Ohbiki M, Goto T, Morishita T, Seto A, Ozawa Y, Miyamura K
International Journal of Hematology Vol. 114 ( 6 ) page： 682 - 690 2021.12
-
A Phase I/II Multicenter Trial of HLA-Haploidentical PBSCT with PTCy for Aggressive Adult T Cell Leukemia/Lymphoma. Reviewed
Tanaka T, Nakamae H, Ito A, Fuji S, Hirose A, Eto T, Henzan H, Takase K, Yamasaki S, Makiyama J, Moriuchi Y, Choi I, Nakano N, Hiramoto N, Kato K, Sato T, Sawayama Y, Kim SW, Inoue Y, Inamoto Y, Fukuda T
Transplantation and cellular therapy Vol. 27 ( 11 ) page： 928.e1 - 928.e7 2021.11
-
A case of sporadic late-onset nemaline myopathy with monoclonal gammopathy of undetermined significance: long-term observation of neurological symptoms after autologous stem-cell transplantation.
Ando T, Sato T, Kurahashi S, Kawaguchi Y, Kagaya Y, Ozawa Y, Hirano S, Goto Y, Mano K, Yokoi S, Nakamura T, Murakami A, Noda S, Kimura S, Sone J, Kuru S, Sobue G, Katsuno M
Nagoya journal of medical science Vol. 83 ( 3 ) page： 641 - 647 2021.8
-
Novel anti-GARP antibody DS-1055a augments anti-tumor immunity by depleting highly suppressive GARP+ regulatory T cells.
Satoh K, Kobayashi Y, Fujimaki K, Hayashi S, Ishida S, Sugiyama D, Sato T, Lim K, Miyamoto M, Kozuma S, Kadokura M, Wakita K, Hata M, Hirahara K, Amano M, Watanabe I, Okamoto A, Tuettenberg A, Jonuleit H, Tanemura A, Maruyama S, Agatsuma T, Wada T, Nishikawa H
International immunology Vol. 33 ( 8 ) page： 435 - 446 2021.7
-
A case of reexpansion pulmonary edema and acute pulmonary thromboembolism associated with diffuse large B-cell lymphoma treated with venovenous extracorporeal membrane oxygenation.
Kazama S, Hiraiwa H, Kimura Y, Ozaki R, Shibata N, Arao Y, Oishi H, Kato H, Kuwayama T, Yamaguchi S, Kondo T, Furusawa K, Morimoto R, Okumura T, Bando YK, Sato T, Shimada K, Kiyoi H, Nakamura G, Yasuda Y, Kasugai D, Ogawa H, Higashi M, Yamamoto T, Jingushi N, Ozaki M, Numaguchi A, Goto Y, Matsuda N, Murohara T
Journal of cardiology cases Vol. 23 ( 1 ) page： 53 - 56 2021.1
-
Day 0 bone marrow pathology of allogeneic hematopoietic stem cell transplantation is a novel prognostic factor in myeloid malignancies.
Sato T, Kawashima N, Ito M, Atsuta Y, Kagaya Y, Seto A, Morishita T, Fukushima N, Ozawa Y, Miyamura K
Blood cell therapy Vol. 3 ( 4 ) page： 84 - 91 2020.11
-
Higher Peak Tacrolimus Concentrations after Allogeneic Hematopoietic Stem Cell Transplantation Increase the Risk of Endothelial Cell Damage Complications.
Morishita T, Okabe M, Kawaguchi Y, Lee Y, Ohbiki M, Osaki M, Goto M, Araie H, Sato T, Goto T, Ozawa Y, Miyamura K
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation Vol. 24 ( 12 ) page： 2509 - 2516 2018.12
-
Iodine staining and p16 immunohistochemistry as a novel screening for secondary esophageal neoplasm after hematopoietic stem cell transplantation.
Sato T, Seto A, Kagaya Y, Kawashima N, Koyama D, Morishita T, Ozawa Y, Miyamura K, Yamaguchi T, Haruta JI, Ito M
Bone marrow transplantation Vol. 53 ( 10 ) page： 1359 - 1363 2018.10
-
Successful treatment with allogeneic stem cell transplantation followed by DLI and TKIs for e6a2 BCR-ABL-positive acute myeloid leukaemia: A case report and literature review.
Harada Y, Nishiwaki S, Sugimoto T, Onodera K, Goto T, Sato T, Kamoshita S, Kawashima N, Seto A, Okuno S, Yamamoto S, Iwasaki T, Ozawa Y, Miyamura K, Akatsuka Y, Sugiura I
Medicine Vol. 96 ( 50 ) page： e9160 2017.12
-
Long-term outcomes of allogeneic hematopoietic cell transplantation with intensified myeloablative conditioning for refractory myeloid malignancy.
Kawashima N, Inamoto Y, Sato T, Nakashima M, Kagaya Y, Watakabe K, Seto A, Fukushima N, Kurahashi S, Ozawa Y, Miyamura K
Bone marrow transplantation Vol. 51 ( 6 ) page： 869 - 71 2016.6
-
Counterbalance between RB inactivation and miR-17-92 overexpression in reactive oxygen species and DNA damage induction in lung cancers.
Ebi H, Sato T, Sugito N, Hosono Y, Yatabe Y, Matsuyama Y, Yamaguchi T, Osada H, Suzuki M, Takahashi T
Oncogene Vol. 28 ( 38 ) page： 3371 - 9 2009.9
-
Relationship of deregulated signaling converging onto mTOR with prognosis and classification of lung adenocarcinoma shown by two independent in silico analyses.
Ebi H, Tomida S, Takeuchi T, Arima C, Sato T, Mitsudomi T, Yatabe Y, Osada H, Takahashi T
Cancer research Vol. 69 ( 9 ) page： 4027 - 35 2009.5
Presentations 8
-
抗PD-L1抗体治療後に免疫関連有害事象として後天性赤芽球癆を発症した一例
佐藤貴彦, 長谷哲成, 古川勝也, 葉名尻良, 牛島洋子, 島田和之, 石川裕一, 寺倉精太郎, 清井仁
第13回日本血液学会東海地方会 2024.6.9 日本血液学会東海地方会
-
Sustained inhibition of CSF1R signaling effectively augments antitumor immune responses through inhibiting tumor-associated macrophages International conference
Takahiko Sato, Daisuke Sugiyama, Yasuhiro Kojima, Satomi Hattori, Kazuki Sone, Tomohiro Ishikawa, Yuichi Ishikawa, Takuma Kato, Hitoshi Kiyoi, Hiroyoshi Nishikawa
American Association for Cancer Research (AACR) Annual Meeting 2024 2024.4.8 American Association for Cancer Research
-
大細胞型B細胞リンパ腫患者に対するCAR-T細胞療法の高齢者と若年者における効果と安全性の比較
葉名尻 良, 佐藤 貴彦, 古川 勝也, 牛島 洋子, 島田 和之, 石川 裕一, 寺倉 精太郎, 清井 仁
第47回日本造血・免疫細胞療法学会総会 2025.2.28 日本造血・免疫細胞療法学会
-
Axi-cel投与後早期の発熱による重症CAR-AEの予測
若林浩也, 寺倉精太郎, 石際康平, 小原史也, 平野志帆, 横田裕史, 桑野史穂美, 古川勝也, 島田和之, 佐藤貴彦, 葉名尻良, 清井仁
第47回日本造血・免疫細胞療法学会総会 2025.3.1 日本造血・免疫細胞療法学会
-
末梢血CAR T細胞におけるCD4/CD8比がB細胞リンパ腫の治療効果と毒性に与える影響
葉名尻良, 佐藤 貴彦, 古川 勝也, 牛島 洋子, 島田 和之, 石川 裕一, 寺倉 精太郎, 清井 仁
第86回日本血液学会学術集会 2024.10.11 日本血液学会
-
AML-PDX治療モデルのシングルセル解析によるFLT3阻害剤耐性化機構の解明
金 貞姫, 石川 裕一, 牛島 洋子, 佐藤 貴彦, 鈴木 祐太朗, 西野 貴紀, 鵜飼 俊, 岩田 哲, 紅 朋浩, 日野原 邦彦, 清井 仁
第86回日本血液学会学術集会 2024.10.11 日本血液学会
-
Novel CSF1R inhibitor, FF-10101, strongly inhibit tumor-associated macrophages and improve anti-tumor response
Takahiko Sato, Daisuke Sugiyama, Yasuhiro Kojima, Satomi Hattori, Kazuki Sone, Yuichi Ishikawa, Hiroyoshi Nishikawa, Hitoshi Kiyoi
2023.9.21
-
FF-10101, a novel CSF1R inhibitor, strongly inhibit tumor-associated macrophages and improve anti-tumor response International conference
Takahiko Sato, Daisuke Sugiyama, Yasuhiro Kojima, Satomi Hattori, Kazuki Sone, Yuichi Ishikawa, Hitoshi Kiyoi, Hiroyoshi Nishikawa
2nd JCA-AACR Precision Cancer Medicine International Conference 2023.6.29